- Home
- IBCP vs LENZ Comparison
IBCP vs LENZ Comparison
Compare IBCP & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBCP
- LENZ
- Stock Information
- Founded
- IBCP 1864
- LENZ 2019
- Country
- IBCP United States
- LENZ United States
- Employees
- IBCP N/A
- LENZ N/A
- Industry
- IBCP Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- IBCP Finance
- LENZ Health Care
- Exchange
- IBCP Nasdaq
- LENZ Nasdaq
- Market Cap
- IBCP N/A
- LENZ 729.6M
- IPO Year
- IBCP N/A
- LENZ 2021
- Fundamental
- Price
- IBCP $30.83
- LENZ $25.20
- Analyst Decision
- IBCP Hold
- LENZ Strong Buy
- Analyst Count
- IBCP 3
- LENZ 6
- Target Price
- IBCP $39.17
- LENZ $38.00
- AVG Volume (30 Days)
- IBCP 101.6K
- LENZ 256.9K
- Earning Date
- IBCP 04-24-2025
- LENZ 03-19-2025
- Dividend Yield
- IBCP 3.37%
- LENZ N/A
- EPS Growth
- IBCP 13.26
- LENZ N/A
- EPS
- IBCP 3.16
- LENZ N/A
- Revenue
- IBCP $218,142,000.00
- LENZ N/A
- Revenue This Year
- IBCP N/A
- LENZ N/A
- Revenue Next Year
- IBCP $6.56
- LENZ $535.40
- P/E Ratio
- IBCP $9.77
- LENZ N/A
- Revenue Growth
- IBCP 8.64
- LENZ N/A
- 52 Week Low
- IBCP $22.53
- LENZ $14.42
- 52 Week High
- IBCP $40.32
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- IBCP 36.96
- LENZ 46.21
- Support Level
- IBCP $31.25
- LENZ $25.17
- Resistance Level
- IBCP $32.04
- LENZ $27.89
- Average True Range (ATR)
- IBCP 0.72
- LENZ 1.74
- MACD
- IBCP 0.17
- LENZ 0.08
- Stochastic Oscillator
- IBCP 43.81
- LENZ 36.46
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.